Aegon Completes Sale of Unirobe Meeùs Groep
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- Moderna shares rise ahead of Thursday earnings report
- AMD forecast eases AI spending fears as data-center sales surge
- Broadcom shares climb as AI chip financing deal supports rally
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Allergen (AGN) PT Lowered to $221 at RBC Capital; Reiterates Outperform
November 2, 2017 8:39 AM EDTRBC Capital lowered its price target on Allergen (NYSE: AGN) to $221.00 (from $250.00) while maintaining a Outperform rating following the company's 3Q earnings report.
Analyst Randall Stanicky still sees unlocked value and expect shareholder pressure to increase and add share support especially if that... More
Allergan (AGN) Should Be Up - Evercore ISI's Raffat
November 1, 2017 10:34 AM EDTEvercore ISI analyst Umer Raffat argues that Allergan (NYSE: AGN) stock should be up and thinks the call went well.
Raffat notes management was very clear about expectations into next year. They also provided clarity on milestone payments etc. over next few years.
From his perspective, the 3 most important things on the call... More



